A Pandemic Silver Lining? Optimizing Internal Collaboration Between Medical Affairs, Compliance, Legal, Regulatory and Market Access Roles in a Post-Pandemic MedTech World
In this second of a two-part presentation we will hear from experienced medical device industry professionals in medical affairs, regulatory affairs and healthcare compliance on the post-pandemic future and how, in this new environment, we can advance innovation, improve patient care and minimize risk.
- Review “Lessons Learned” from the Pandemic: How the pandemic has revealed opportunities for the MedTech Industry to support improvements in innovation; communications and engagement; and management of resources and systems.
- Identify key internal and external stakeholders in the MedTech healthcare environment and learn how Medical Affairs professionals can facilitate communications among them.
- Review how the MedTech Industry generally, and through Medical Affairs, may impact the future – what to start doing, stop doing and continue doing.
MAPS members, please log in for immediate access:
Nonmembers, access this content in one of the following ways:
SPEAKER: Ann Ford
Partner/Managing Director HPS Advise, Hall, Prangle & SchoonveldMedical Affairs Professional Society
SPEAKER: Greg Christopherson
Vice President of Medical Affairs, Medline Industries, Inc,Medical Affairs Professional Society
SPEAKER: Phil Desjardins, JD
Vice President, Global Regulatory Affairs Spine and Medical Device Regulatory Policy, Johnson & Johnson Medical DevicesMedical Affairs Professional Society
SPEAKER: David Macarios, MBA, MSc
Head, North American Medical Affairs Health Economics and Outcomes Research and Payer Engagement, EMD Serono, Inc.Medical Affairs Professional Society